Highlights Teijin Limited

Equities

3401

JP3544000007

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-01 am EDT			5-day change	1st Jan Change
1,542 ^JPY	+0.16%		+3.73%	+15.41%

Feb. 09	Teijin Swings to Fiscal Q1-Q3 Profit	MT
Feb. 08	Transcript : Teijin Limited, Q3 2024 Earnings Call, Feb 08, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	Mar. 27	FA
Teijin Swings to Fiscal Q1-Q3 Profit	Feb. 09	MT
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024	Feb. 08	CI
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024	Feb. 08	CI
Ascendis Pharma A/S Announces Strategic Partnership with Teijin Limited in Japan	Nov. 29	CI
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024	Nov. 06	CI
Ex-dividend day for interim dividend	23-09-27	FA
Tipcomposite Co.,Ltd. signed a share transfer agreement to acquire a 99.1% stake in GH Craft Ltd. from Teijin Limited	23-08-31	CI
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024	23-08-06	CI
Teijin Limited Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	23-08-06	CI
Teijin Limited Provides Dividend Guidance for the End of Second Quarter of Full Year Ending March 31, 2024	23-08-06	CI
Teijin Announces Establishment of A Subsidiary by Company Split	23-05-31	CI
Teijin Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10	CI
Teijin Limited Announces Dividend for the Fourth Quarter of Fiscal Year Ended 2022	23-05-10	CI
Teijin Limited Provides Dividend Guidance for the Fiscal Year 2023	23-05-10	CI
Teijin Limited Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-05-10	CI
Teijin Limited Provides Dividend Guidance for the Second Quarter of 2023	23-05-10	CI
Teijin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-10	CI
Teijin, Japan Tissue Engineering to Team Up with Resilience US for Regenerative Medicine Technologies Development; Shares Climb 16%	23-04-21	MT
Teijin Limited and Japan Tissue Engineering Co., Ltd. Form Business Alliance to Spur Development of New Regenerative Medicine Technologies	23-04-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Teijin Limited

Equities

3401

JP3544000007

Highlights

Filters